Explore 3 Stock Ideas & Industry Insights Download Free Report

800-234-336
Shopping Cart 0
countryflagNZ
Login

Nano X Imaging Ltd

Healthcare US NNOX

2.035USD
0.17(8.82%)

Last update at 2026-06-04T15:30:00Z

Day Range

1.852.04
LowHigh

52 Week Range

4.8922.69
LowHigh

Fundamentals

  • Previous Close 1.87
  • Market Cap490.63M
  • Volume770969
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-44.04900M
  • Revenue TTM10.01M
  • Revenue Per Share TTM0.17
  • Gross Profit TTM -6.88000M
  • Diluted EPS TTM-1.09

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -108.92100M -61.84600M -43.81500M -22.56300M -1.90900M
Minority interest - - - - -
Net income -105.24300M -61.79800M -43.49900M -22.55500M -1.90900M
Selling general administrative 41.25M 34.71M 22.27M 18.30M 1.02M
Selling and marketing expenses 4.38M 7.03M 12.45M 1.56M 0.21M
Gross profit -6.88000M -1.51200M - - -
Reconciled depreciation 11.51M 2.29M 0.21M 0.05M 0.04M
Ebit -109.71000M -63.85000M -44.13100M -22.57100M -1.90400M
Ebitda -37.19400M -61.55800M -43.92300M -22.51800M -1.86900M
Depreciation and amortization 72.52M 2.29M 0.21M 0.05M 0.04M
Non operating income net other - - - - -
Operating income -109.71000M -61.55800M -43.92300M -22.57100M -1.90400M
Other operating expenses 87.79M 62.86M 43.92M 22.57M 1.90M
Interest expense 60.22M 2.00M 0.11M 0.00800M 0.00500M
Tax provision -3.67800M -0.04800M - - -
Interest income - - - - -
Net interest income 0.79M -0.28800M 0.11M 0.00800M -0.00500M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -3.67800M -0.04800M -0.31600M -0.00800M 0.00500M
Total revenue 8.58M 1.30M 0.00000M 0.00000M 0.00000M
Total operating expenses 72.33M 60.05M 43.92M 22.57M 1.90M
Cost of revenue 15.46M 2.82M - - -
Total other income expense net 0.79M -0.28800M 0.11M 0.00800M -0.00500M
Discontinued operations - - - - -
Net income from continuing ops -105.24300M -61.79800M -43.81500M -22.56300M -1.90900M
Net income applicable to common shares -113.24300M -61.79800M -43.81500M -22.56300M -1.90900M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 218.65M 253.93M 363.17M 236.15M 11.87M
Intangible assets 80.61M 91.22M 160.12M - -
Earning assets - - - - -
Other current assets 2.32M 1.45M 1.97M 6.33M 1.56M
Total liab 23.13M 29.25M 71.02M 5.40M 20.65M
Total stockholder equity 195.51M 224.68M 292.15M 230.75M -8.77800M
Deferred long term liab - - - - 1.20M
Other current liab 7.33M 12.53M 48.34M 3.53M 17.82M
Common stock 0.17M 0.16M 0.15M 0.13M 0.07M
Capital stock 0.17M 0.16M 0.15M 0.13M 0.07M
Retained earnings -320.23300M -251.45700M -146.21400M -84.41600M -40.60100M
Other liab - 8.30M 13.53M - -
Good will 0.00000M 7.42M 58.30M - -
Other assets 0.00000M 34.67M 1.18M 6.29M 1.48M
Cash 56.42M 38.46M 66.64M 213.47M 8.07M
Cash and equivalents - - - - -
Total current liabilities 15.52M 17.07M 52.75M 4.48M 20.26M
Current deferred revenue 0.54M 0.18M 0.25M - 1.83M
Net debt -48.02700M -33.84400M -60.87300M -212.02600M -7.54600M
Short term debt 4.35M 0.74M 1.03M 0.52M 0.14M
Short long term debt 3.49M - 0.14M - -
Short long term debt total 8.40M 4.62M 5.77M 1.44M 0.53M
Other stockholder equity 515.89M 477.95M 438.82M 315.03M 31.75M
Property plant equipment - 12.96M 39.16M 10.06M 0.75M
Total current assets 88.64M 82.46M 94.86M 219.79M 9.64M
Long term investments 0.00000M 25.20M 67.84M - -
Net tangible assets - 118.04M 132.02M 230.75M -8.77800M
Short term investments 26.01M 39.16M 22.07M - -
Net receivables 1.48M 0.98M 1.05M - -
Long term debt - 3.48M 3.80M - -
Inventory 2.36M 2.41M 3.13M - -
Accounts payable 3.30M 3.62M 3.13M 0.43M 0.47M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -0.30500M -1.97400M -0.60700M -0.34400M -0.13600M
Additional paid in capital - - - - -
Common stock total equity - - - 0.13M 0.07M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 2.16M 2.93M 1.18M 0.98M 1.48M
Deferred long term asset charges - - - - -
Non current assets total 130.01M 171.47M 268.31M 16.36M 2.23M
Capital lease obligations 4.91M 1.14M 1.83M 1.44M 0.53M
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments 14.61M -116.32000M -13.93700M -0.12500M -0.07300M
Change to liabilities 0.39M 0.00000M -0.10300M 0.39M -0.13400M
Total cashflows from investing activities 14.61M -116.32000M -13.93700M -0.12500M -0.07300M
Net borrowings -0.14500M -0.14500M -0.14500M -0.14500M -
Total cash from financing activities 0.80M 7.38M 240.99M 13.86M 3.68M
Change to operating activities 10.97M 10.97M -2.55800M 0.35M -1.77800M
Net income -105.24300M -61.79800M -43.81500M -22.56300M -1.90900M
Change in cash -28.24300M -147.01200M 205.57M 8.21M -0.06000M
Begin period cash flow 66.77M 213.78M 8.22M 0.00500M 0.07M
End period cash flow 38.53M 66.77M 213.78M 8.22M 0.00500M
Total cash from operating activities -43.38500M -38.07100M -21.48700M -5.52400M -3.67100M
Issuance of capital stock 0.00000M 0.00000M 240.36M 14.04M 3.68M
Depreciation 11.51M 2.29M 0.21M 0.05M 0.04M
Other cashflows from investing activities - -116.32000M -116.32000M -116.32000M -116.32000M
Dividends paid - - - - -
Change to inventory - 0.86M - - -
Change to account receivables 0.07M -0.04000M 0.07M 0.07M -
Sale purchase of stock - - - - -
Other cashflows from financing activities 0.80M 7.38M 0.63M -0.17700M -0.07300M
Change to netincome 46.91M 23.73M 24.78M 16.25M 0.12M
Capital expenditures 7.17M 23.16M 13.94M 0.12M 0.07M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -16.94500M 2.75M -2.66100M 0.74M -1.91200M
Stock based compensation 18.62M 18.81M 24.78M 16.25M 0.12M
Other non cash items 52.40M -0.00200M - - -
Free cash flow -50.55600M -61.22900M -35.42400M -5.64900M -3.74400M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
NNOX
Nano X Imaging Ltd		 0.17 8.82% 2.04 - - 56.64 2.77 48.93 -7.4123
ABT
Abbott Laboratories		 3.11 3.58% 90.10 25.97 17.24 3.57 3.20 3.81 16.75
SYK
Stryker Corporation		 5.55 1.88% 300.55 44.07 24.94 5.51 6.12 6.05 25.73
MDT
Medtronic PLC		 3.60 4.62% 81.55 26.60 15.87 3.35 2.08 3.90 14.12
BSX
Boston Scientific Corp		 0.76 1.58% 48.45 31.49 17.24 4.41 3.65 4.88 19.19

Reports Covered

Stock Research & News

View All

Profile

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source, and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company is headquartered in Petach Tikva, Israel.

Nano X Imaging Ltd

Communication Center, Neve Ilan, Israel, 9085000

Key Executives

Name Title Year Born
Ms. Marina Gofman Feler Chief Legal Officer NA
Mr. Ran Poliakine Founder & Chairman 1969
Mr. Erez I. Meltzer CEO & Director 1957
Ran Daniel Chief Financial Officer 1968
Mr. Tal Shank VP of Corp. Devel. 1978
Ms. Tamar Aharon Cohen Exec. VP & Chief Marketing Officer 1977
Mr. Gilad Yron Chief Bus. Officer 1973
Mr. James M. Dara GM of Source & Services Division and Head of Nanox USA 1970
Ms. Lydia Edwards Pres of Nanox US NA
Dr. Ilung Kim Ph.D. Head of Nanox Korea 1959

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.